{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:06:19Z","timestamp":1789200379506,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12767-x","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:40:12Z","timestamp":1789198812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Overcoming cancer resistance in pancreatic cancer: toward dynamic precision oncology"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4829-4306","authenticated-orcid":false,"given":"Takehiro","family":"Okabayashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoyasu","family":"Tabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teppei","family":"Tokumaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunao","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuta","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"issue":"1","key":"12767_CR1","doi-asserted-by":"publisher","first-page":"e70043","DOI":"10.3322\/caac.70043","volume":"76","author":"RL Siegel","year":"2026","unstructured":"Siegel RL, Kratzer TB, Wagle NS, Sung H, Jemal A (2026) Cancer statistics, 2026. CA Cancer J Clin 76(1):e70043. https:\/\/doi.org\/10.3322\/caac.70043","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"12767_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","volume":"21","author":"ZI Hu","year":"2024","unstructured":"Hu ZI, O\u2019Reilly EM (2024) Therapeutic developments in pancreatic cancer. Nat Rev Gastroenterol Hepatol 21(1):7\u201324. https:\/\/doi.org\/10.1038\/s41575-023-00840-w","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"12767_CR3","doi-asserted-by":"publisher","first-page":"101146","DOI":"10.1016\/j.drup.2024.101146","volume":"77","author":"A Shah","year":"2024","unstructured":"Shah A, Ganguly K, Rauth S, Sheree SS, Khan I, Ganti AK, Ponnusamy MP, Kumar S, Jain M, Batra SK (2024) Unveiling the resistance to therapies in pancreatic ductal adenocarcinoma. Drug Resist Updat 77:101146. https:\/\/doi.org\/10.1016\/j.drup.2024.101146","journal-title":"Drug Resist Updat"},{"issue":"12","key":"12767_CR4","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41571-025-01077-z","volume":"22","author":"HC Kung","year":"2025","unstructured":"Kung HC, Zheng KW, Zimmerman JW, Zheng L (2025) The tumour microenvironment in pancreatic cancer - new clinical challenges, but more opportunities. Nat Rev Clin Oncol 22(12):969\u2013995. https:\/\/doi.org\/10.1038\/s41571-025-01077-z","journal-title":"Nat Rev Clin Oncol"},{"key":"12767_CR5","doi-asserted-by":"publisher","first-page":"102268","DOI":"10.1016\/j.suronc.2025.102268","volume":"63","author":"RA Safyan","year":"2025","unstructured":"Safyan RA, Chiorean EG (2025) Updates on molecular targets and clinical trials with targeted therapies for pancreatic cancer. Surg Oncol 63:102268. https:\/\/doi.org\/10.1016\/j.suronc.2025.102268","journal-title":"Surg Oncol"},{"issue":"7","key":"12767_CR6","doi-asserted-by":"publisher","first-page":"104396","DOI":"10.1016\/j.drudis.2025.104396","volume":"30","author":"C Suyal","year":"2025","unstructured":"Suyal C, Shenoy KM, Kishore A, Kini SG (2025) Structure-activity relationships of KRAS-G12D inhibitors for pancreatic cancer. Drug Discov Today 30(7):104396. https:\/\/doi.org\/10.1016\/j.drudis.2025.104396","journal-title":"Drug Discov Today"},{"issue":"11","key":"12767_CR7","doi-asserted-by":"publisher","first-page":"9313","DOI":"10.3390\/ijms24119313","volume":"24","author":"E Gurreri","year":"2023","unstructured":"Gurreri E, Genovese G, Perelli L, Agostini A, Piro G, Carbone C, Tortora G (2023) KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy. Int J Mol Sci 24(11):9313. https:\/\/doi.org\/10.3390\/ijms24119313","journal-title":"Int J Mol Sci"},{"issue":"22","key":"12767_CR8","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1158\/1078-0432.CCR-25-0758","volume":"31","author":"MM Steiniche","year":"2025","unstructured":"Steiniche MM, Lindgaard SC, Chen IM, Johansen JS, Andersen RF, Hansen TF, Jensen LH, Rasmussen LS, Johansen MW, Ladekarl M, Jakobsen AKM, Spindler KG (2025) The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST. Clin Cancer Res 31(22):4720\u20134729. https:\/\/doi.org\/10.1158\/1078-0432.CCR-25-0758","journal-title":"Clin Cancer Res"},{"key":"12767_CR9","doi-asserted-by":"publisher","first-page":"100441","DOI":"10.1016\/j.jlb.2025.100441","volume":"10","author":"MM Steiniche","year":"2025","unstructured":"Steiniche MM, Callesen LB, Vlk EH, Ventzel L, Timm S, Andersen RF, Lindgaard SC, Hansen TF, Ladekarl M, Spindler KG (2025) Circulating tumour DNA (ctDNA) as a predictor of progression-free and overall survival in non-resectable pancreatic cancer: a systematic review and meta-analysis. J Liq Biopsy 10:100441. https:\/\/doi.org\/10.1016\/j.jlb.2025.100441","journal-title":"J Liq Biopsy"},{"issue":"24","key":"12767_CR10","doi-asserted-by":"publisher","first-page":"e70203","DOI":"10.1111\/1759-7714.70203","volume":"16","author":"K Shi","year":"2025","unstructured":"Shi K, Li A, Targeting (2025) KRAS G12D: Advances in Inhibitor Design. Thorac Cancer 16(24):e70203. https:\/\/doi.org\/10.1111\/1759-7714.70203","journal-title":"Thorac Cancer"},{"issue":"11","key":"12767_CR11","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1158\/2159-8290.CD-24-0177","volume":"14","author":"J Dilly","year":"2024","unstructured":"Dilly J, Hoffman MT, Abbassi L, Li Z, Paradiso F, Parent BD, Hennessey CJ, Jordan AC, Morgado M, Dasgupta S, Uribe GA, Yang A, Kapner KS, Hambitzer FP, Qiang L, Feng H, Geisberg J, Wang J, Evans KE, Lyu H, Schalck A, Feng N, Lopez AM, Bristow CA, Kim MP, Rajapakshe KI, Bahrambeigi V, Roth JA, Garg K, Guerrero PA, Stanger BZ, Cristea S, Lowe SW, Baslan T, Van Allen EM, Mancias JD, Chan E, Anderson A, Katlinskaya YV, Shalek AK, Hong DS, Pant S, Hallin J, Anderes K, Olson P, Heffernan TP, Chugh S, Christensen JG, Maitra A, Wolpin BM, Raghavan S, Nowak JA, Winter PS, Dougan SK, Aguirre AJ (2024) Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer. Cancer Discov 14(11):2135\u20132161. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-0177","journal-title":"Cancer Discov"},{"key":"12767_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.semcancer.2022.12.004","volume":"88","author":"GP Nagaraju","year":"2023","unstructured":"Nagaraju GP, Farran B, Luong T, El-Rayes BF (2023) Understanding the molecular mechanisms that regulate pancreatic cancer stem cell formation, stemness and chemoresistance: A brief overview. Semin Cancer Biol 88:67\u201380. https:\/\/doi.org\/10.1016\/j.semcancer.2022.12.004","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"12767_CR13","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/s41392-023-01383-x","volume":"8","author":"ZD Shi","year":"2023","unstructured":"Shi ZD, Pang K, Wu ZX, Dong Y, Hao L, Qin JX, Wang W, Chen ZS, Han CH (2023) Tumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies. Signal Transduct Target Ther 8(1):113. https:\/\/doi.org\/10.1038\/s41392-023-01383-x","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"12767_CR14","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","volume":"4","author":"A P\u00e9rez-Gonz\u00e1lez","year":"2023","unstructured":"P\u00e9rez-Gonz\u00e1lez A, B\u00e9vant K, Blanpain C (2023) Cancer cell plasticity during tumor progression, metastasis and response to therapy. Nat Cancer 4(8):1063\u20131082. https:\/\/doi.org\/10.1038\/s43018-023-00595-y","journal-title":"Nat Cancer"},{"issue":"11","key":"12767_CR15","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1158\/1078-0432.CCR-25-1788","volume":"32","author":"Q Lin","year":"2026","unstructured":"Lin Q, Morales-Giron AA, Sander C, Curtis JM, Barnes H, Patel PS, Fece de la Cruz F, Riedl JM, Matsubara H, Nakamura H, Liss AS, Corcoran RB (2026) Overcoming Adaptive Resistance to KRASG12D Blockade in Pancreatic Cancer through Vertical Pathway Inhibition. Clin Cancer Res 32(11):2279\u20132292. https:\/\/doi.org\/10.1158\/1078-0432.CCR-25-1788","journal-title":"Clin Cancer Res"},{"key":"12767_CR16","doi-asserted-by":"publisher","first-page":"1402128","DOI":"10.3389\/fonc.2024.1402128","volume":"14","author":"SA Long","year":"2024","unstructured":"Long SA, Amparo AM, Goodhart G, Ahmad SA, Waters AM (2024) Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment. Front Oncol 14:1402128. https:\/\/doi.org\/10.3389\/fonc.2024.1402128","journal-title":"Front Oncol"},{"key":"12767_CR17","doi-asserted-by":"publisher","first-page":"116492","DOI":"10.1016\/j.bcp.2024.116492","volume":"229","author":"M Espona-Fiedler","year":"2024","unstructured":"Espona-Fiedler M, Patthey C, Lindblad S, Sarr\u00f3 I, \u00d6hlund D (2024) Overcoming therapy resistance in pancreatic cancer: New insights and future directions. Biochem Pharmacol 229:116492. https:\/\/doi.org\/10.1016\/j.bcp.2024.116492","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"12767_CR18","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrc.2016.66","volume":"16","author":"A Makohon-Moore","year":"2016","unstructured":"Makohon-Moore A, Iacobuzio-Donahue CA (2016) Pancreatic cancer biology and genetics from an evolutionary perspective. Nat Rev Cancer 16(9):553\u2013565. https:\/\/doi.org\/10.1038\/nrc.2016.66","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"12767_CR19","doi-asserted-by":"publisher","first-page":"189220","DOI":"10.1016\/j.bbcan.2024.189220","volume":"1879","author":"H Yao","year":"2024","unstructured":"Yao H, Luo L, Li R, Zhao Y, Zhang L, Pe\u0161i\u0107 M, Cai L, Li L (2024) New insight into the role of SMAD4 mutation\/deficiency in the prognosis and therapeutic resistance of pancreatic ductal adenocarcinomas. Biochim Biophys Acta Rev Cancer 1879(6):189220. https:\/\/doi.org\/10.1016\/j.bbcan.2024.189220","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"12767_CR20","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13046-021-01960-4","volume":"40","author":"CH Chang","year":"2021","unstructured":"Chang CH, Pauklin S (2021) ROS and TGF\u03b2: from pancreatic tumour growth to metastasis. J Exp Clin Cancer Res 40(1):152. https:\/\/doi.org\/10.1186\/s13046-021-01960-4","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"12767_CR21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s10555-023-10164-5","volume":"43","author":"MH Uddin","year":"2024","unstructured":"Uddin MH, Zhang D, Muqbil I, El-Rayes BF, Chen H, Philip PA, Azmi AS (2024) Deciphering cellular plasticity in pancreatic cancer for effective treatments. Cancer Metastasis Rev 43(1):393\u2013408. https:\/\/doi.org\/10.1007\/s10555-023-10164-5","journal-title":"Cancer Metastasis Rev"},{"issue":"8","key":"12767_CR22","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41419-024-06930-0","volume":"15","author":"H Wu","year":"2024","unstructured":"Wu H, Fu M, Wu M, Cao Z, Zhang Q, Liu Z (2024) Emerging mechanisms and promising approaches in pancreatic cancer metabolism. Cell Death Dis 15(8):553. https:\/\/doi.org\/10.1038\/s41419-024-06930-0","journal-title":"Cell Death Dis"},{"issue":"8","key":"12767_CR23","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","volume":"186","author":"CJ Halbrook","year":"2023","unstructured":"Halbrook CJ, Lyssiotis CA, Pasca di Magliano M, Maitra A (2023) Pancreatic cancer: Advances and challenges. Cell 186(8):1729\u20131754. https:\/\/doi.org\/10.1016\/j.cell.2023.02.014","journal-title":"Cell"},{"issue":"1","key":"12767_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41698-024-00681-z","volume":"8","author":"Y Ju","year":"2024","unstructured":"Ju Y, Xu D, Liao MM, Sun Y, Bao WD, Yao F, Ma L (2024) Barriers and opportunities in pancreatic cancer immunotherapy. NPJ Precis Oncol 8(1):199. https:\/\/doi.org\/10.1038\/s41698-024-00681-z","journal-title":"NPJ Precis Oncol"},{"issue":"42","key":"12767_CR25","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1038\/s41388-022-02448-x","volume":"41","author":"T Evan","year":"2022","unstructured":"Evan T, Wang VM, Behrens A (2022) The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma. Oncogene 41(42):4686\u20134695. https:\/\/doi.org\/10.1038\/s41388-022-02448-x","journal-title":"Oncogene"},{"issue":"8","key":"12767_CR26","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41588-022-01134-8","volume":"54","author":"WL Hwang","year":"2022","unstructured":"Hwang WL, Jagadeesh KA, Guo JA, Hoffman HI, Yadollahpour P, Reeves JW, Mohan R, Drokhlyansky E, Van Wittenberghe N, Ashenberg O, Farhi SL, Schapiro D, Divakar P, Miller E, Zollinger DR, Eng G, Schenkel JM, Su J, Shiau C, Yu P, Freed-Pastor WA, Abbondanza D, Mehta A, Gould J, Lambden C, Porter CBM, Tsankov A, Dionne D, Waldman J, Cuoco MS, Nguyen L, Delorey T, Phillips D, Barth JL, Kem M, Rodrigues C, Ciprani D, Roldan J, Zelga P, Jorgji V, Chen JH, Ely Z, Zhao D, Fuhrman K, Fropf R, Beechem JM, Loeffler JS, Ryan DP, Weekes CD, Ferrone CR, Qadan M, Aryee MJ, Jain RK, Neuberg DS, Wo JY, Hong TS, Xavier R, Aguirre AJ, Rozenblatt-Rosen O, Mino-Kenudson M, Castillo CF, Liss AS, Ting DT, Jacks T, Regev A (2022) Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment. Nat Genet 54(8):1178\u20131191. https:\/\/doi.org\/10.1038\/s41588-022-01134-8","journal-title":"Nat Genet"},{"issue":"6","key":"12767_CR27","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s41551-024-01273-9","volume":"9","author":"A Papargyriou","year":"2025","unstructured":"Papargyriou A, Najajreh M, Cook DP, Maurer CH, B\u00e4rthel S, Messal HA, Ravichandran SK, Richter T, Knolle M, Metzler T, Shastri AR, \u00d6llinger R, Jasper J, Schmidleitner L, Wang S, Schneeweis C, Ishikawa-Ankerhold H, Engleitner T, Mataite L, Semina M, Trabulssi H, Lange S, Ravichandra A, Schuster M, Mueller S, Peschke K, Sch\u00e4fer A, Dobiasch S, Combs SE, Schmid RM, Bausch AR, Braren R, Heid I, Scheel CH, Schneider G, Zeigerer A, Luecken MD, Steiger K, Kaissis G, van Rheenen J, Theis FJ, Saur D, Rad R, Reichert M (2025) Heterogeneity-driven phenotypic plasticity and treatment response in branched-organoid models of pancreatic ductal adenocarcinoma. Nat Biomed Eng 9(6):836\u2013864. https:\/\/doi.org\/10.1038\/s41551-024-01273-9","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"12767_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41421-024-00720-w","volume":"10","author":"Y Saito","year":"2024","unstructured":"Saito Y, Xiao Y, Yao J, Li Y, Liu W, Yuzhalin AE, Shyu YM, Li H, Yuan X, Li P, Zhang Q, Li Z, Wei Y, Yin X, Zhao J, Kariminia SM, Wu YC, Wang J, Yang J, Xia W, Sun Y, Jho EH, Chiao PJ, Hwang RF, Ying H, Wang H, Zhao Z, Maitra A, Hung MC, DePinho RA, Yu D (2024) Targeting a chemo-induced adaptive signaling circuit confers therapeutic vulnerabilities in pancreatic cancer. Cell Discov 10(1):109. https:\/\/doi.org\/10.1038\/s41421-024-00720-w","journal-title":"Cell Discov"},{"issue":"1","key":"12767_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13148-024-01623-z","volume":"16","author":"LK Godfrey","year":"2024","unstructured":"Godfrey LK, Forster J, Liffers ST, Schr\u00f6der C, K\u00f6ster J, Henschel L, Ludwig KU, L\u00e4hnemann D, Trajkovic-Arsic M, Behrens D, Scarpa A, Lawlor RT, Witzke KE, Sitek B, Johnsen SA, Rahmann S, Horsthemke B, Zeschnigk M, Siveke JT (2024) Pancreatic cancer acquires resistance to MAPK pathway inhibition by clonal expansion and adaptive DNA hypermethylation. Clin Epigenetics 16(1):13. https:\/\/doi.org\/10.1186\/s13148-024-01623-z","journal-title":"Clin Epigenetics"},{"issue":"4","key":"12767_CR30","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/s41591-024-02903-0","volume":"30","author":"A Singhal","year":"2024","unstructured":"Singhal A, Li BT, O\u2019Reilly EM (2024) Targeting KRAS in cancer. Nat Med 30(4):969\u2013983. https:\/\/doi.org\/10.1038\/s41591-024-02903-0","journal-title":"Nat Med"},{"issue":"8","key":"12767_CR31","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","volume":"17","author":"AN Hosein","year":"2020","unstructured":"Hosein AN, Brekken RA, Maitra A (2020) Pancreatic cancer stroma: an update on therapeutic targeting strategies. Nat Rev Gastroenterol Hepatol 17(8):487\u2013505. https:\/\/doi.org\/10.1038\/s41575-020-0300-1","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"12767_CR32","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-024-01561-6","volume":"17","author":"P Farhangnia","year":"2024","unstructured":"Farhangnia P, Khorramdelazad H, Nickho H, Delbandi AA (2024) Current and future immunotherapeutic approaches in pancreatic cancer treatment. J Hematol Oncol 17(1):40. https:\/\/doi.org\/10.1186\/s13045-024-01561-6","journal-title":"J Hematol Oncol"},{"issue":"7963","key":"12767_CR33","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41586-023-06063-y","volume":"618","author":"LA Rojas","year":"2023","unstructured":"Rojas LA, Sethna Z, Soares KC, Olcese C, Pang N, Patterson E, Lihm J, Ceglia N, Guasp P, Chu A, Yu R, Chandra AK, Waters T, Ruan J, Amisaki M, Zebboudj A, Odgerel Z, Payne G, Derhovanessian E, M\u00fcller F, Rhee I, Yadav M, Dobrin A, Sadelain M, \u0141uksza M, Cohen N, Tang L, Basturk O, G\u00f6nen M, Katz S, Do RK, Epstein AS, Momtaz P, Park W, Sugarman R, Varghese AM, Won E, Desai A, Wei AC, D\u2019Angelica MI, Kingham TP, Mellman I, Merghoub T, Wolchok JD, Sahin U, T\u00fcreci \u00d6, Greenbaum BD, Jarnagin WR, Drebin J, O\u2019Reilly EM, Balachandran VP (2023) Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer. Nature 618(7963):144\u2013150. https:\/\/doi.org\/10.1038\/s41586-023-06063-y","journal-title":"Nature"},{"issue":"4","key":"12767_CR34","doi-asserted-by":"publisher","first-page":"oyag071","DOI":"10.1093\/oncolo\/oyag071","volume":"31","author":"SD Haldar","year":"2026","unstructured":"Haldar SD, Saj F, Hong SJ, Surana R, Xiao L, Lee JJ, Smaglo B, Zhao D, Zhu H, Huey R, Willis J, Morelli MP, Overman M, McAllister F, Wolff R, Maitra A, Fogelman D, Der C, Pant S (2026) Phase I trial of binimetinib plus hydroxychloroquine in patients with previously treated metastatic pancreatic cancer. Oncologist 31(4):oyag071. https:\/\/doi.org\/10.1093\/oncolo\/oyag071","journal-title":"Oncologist"},{"issue":"4","key":"12767_CR35","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1007\/s10147-025-02713-5","volume":"30","author":"E So","year":"2025","unstructured":"So E, Hayashi H, Shimozaki K, Horie S, Kishimoto S, Chida A, Saito Y, Tsugaru K, Hirata K, Tanishima S, Nishihara H, Kanai T, Hamamoto Y (2025) Clinical utility of comprehensive genomic profiling for advanced pancreatic cancer: insights from real-world data analysis. Int J Clin Oncol 30(4):728\u2013737. https:\/\/doi.org\/10.1007\/s10147-025-02713-5","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"12767_CR36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12029-024-01129-0","volume":"56","author":"M Cox","year":"2025","unstructured":"Cox M, Vitello DJ, Chawla A (2025) The Current Role of Circulating Tumor DNA in the Management of Pancreatic Cancer. J Gastrointest Cancer 56(1):44. https:\/\/doi.org\/10.1007\/s12029-024-01129-0","journal-title":"J Gastrointest Cancer"},{"key":"12767_CR37","doi-asserted-by":"publisher","first-page":"120105","DOI":"10.1016\/j.cca.2024.120105","volume":"567","author":"AK Balaraman","year":"2025","unstructured":"Balaraman AK, Moglad E, Afzal M, Babu MA, Goyal K, Roopashree R, Kaur I, Kumar S, Kumar M, Chauhan AS, Hemalatha S, Gupta G, Ali H (2025) Liquid biopsies and exosomal ncRNA: Transforming pancreatic cancer diagnostics and therapeutics. Clin Chim Acta 567:120105. https:\/\/doi.org\/10.1016\/j.cca.2024.120105","journal-title":"Clin Chim Acta"},{"issue":"9","key":"12767_CR38","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1002\/1878-0261.13472","volume":"17","author":"KH Edland","year":"2023","unstructured":"Edland KH, Tjensvoll K, Oltedal S, Dalen I, Lapin M, Garresori H, Glenjen N, Gilje B, Nordg\u00e5rd O (2023) Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging. Mol Oncol 17(9):1857\u20131870. https:\/\/doi.org\/10.1002\/1878-0261.13472","journal-title":"Mol Oncol"},{"issue":"4","key":"12767_CR39","doi-asserted-by":"publisher","first-page":"e00999","DOI":"10.14309\/ctg.0000000000000999","volume":"17","author":"G Yao","year":"2026","unstructured":"Yao G, Zhang Y, Li H, Teng L, Man Y, Wang S, Liu C, Fan Y, Chen D (2026) Circulating Tumor DNA as a Biomarker in Pancreatic Cancer: Clinical Applications and Challenges. Clin Transl Gastroenterol 17(4):e00999. https:\/\/doi.org\/10.14309\/ctg.0000000000000999","journal-title":"Clin Transl Gastroenterol"},{"issue":"8","key":"12767_CR40","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.annonc.2022.05.520","volume":"33","author":"J Pascual","year":"2022","unstructured":"Pascual J, Attard G, Bidard FC, Curigliano G, De Mattos-Arruda L, Diehn M, Italiano A, Lindberg J, Merker JD, Montagut C, Normanno N, Pantel K, Pentheroudakis G, Popat S, Reis-Filho JS, Tie J, Seoane J, Tarazona N, Yoshino T, Turner NC (2022) ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group. Ann Oncol 33(8):750\u2013768. https:\/\/doi.org\/10.1016\/j.annonc.2022.05.520","journal-title":"Ann Oncol"},{"issue":"6","key":"12767_CR41","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.dld.2026.03.002","volume":"58","author":"S Carrara","year":"2026","unstructured":"Carrara S, Bevere M, Delle Cave D, Gentiluomo M, Esposito I, Luchini C (2026) Liquid biopsy in pancreatic cancer: current advances, limitations, and future perspectives. Dig Liver Dis 58(6):726\u2013736. https:\/\/doi.org\/10.1016\/j.dld.2026.03.002","journal-title":"Dig Liver Dis"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12767-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12767-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12767-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:40:13Z","timestamp":1789198813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12767-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12767"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12767-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"7 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1570"}}